Banaag, Mary A.
HRN: 22-82-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2023
CEFTRIAXONE 1G (VIAL)
04/09/2023
04/16/2023
IV
2 Grams
OD
Complicated UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes